Sign inJoin waitlistJoin the waitlist

Jeffrey Crawford

George Barth Geller Distinguished Professor Emeritus for Research in Cancer · Duke University Hospital

Credentials: · · · · ·

History

Duke University Hospital
Present
Duke University Hospital
Present

Hematology and Medical Oncology
1977–1980
Internal Medicine
1974–1977
Ohio State University College of Medicine
1970–1974

Research

Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
New England Journal of Medicine · 1991 · First of over 10 authors · 1,294 citations
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing…
Journal of Clinical Oncology · 2000 · 1,173 citations
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline
Journal of Clinical Oncology · 2006 · 1,140 citations

Gary Lyman
44 papers
David Dale
35 papers
Harvey Cohen
19 papers
JG
Jennifer Garst
17 papers · 1 as a fellow
Neal Ready
17 papers
Everett Vokes
15 papers
Lin Gu
13 papers · 6 as a resident
Thomas Stinchcombe
13 papers
Jeffrey Clarke
11 papers
John Glaspy
11 papers
SB
Susan Blackwell
10 papers
James Armitage
9 papers

Grants

The Duke University - Duke Cancer Institute National Clinical Trials Network LAPS (UG1) Support Grant
National Cancer Institute · UG1
Contact PI · $3.1M · Duke University
2019–2026
NCI National Clinical Trials Network U10
National Cancer Institute · U10
Contact PI · $2M · Duke University
2014–2019
Cancer and Leukemia Group B
National Cancer Institute · U10
Contact PI · $4.5M · Duke University
1988–2015
Research Training in Cancer Biology and Therapy
National Cancer Institute · T32
Contact PI · $4.8M · Duke University
1978–2013

Clinical trials

G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
Study chair · Completed · Phase 2
Radiation Therapy Oncology Group
2008–2011
Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
Study chair · Terminated · Phase 3
Radiation Therapy Oncology Group
2005